Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Newborn Screening Market, by Product Type
1.4.2 LAMEA Newborn Screening Market, by Test Type
1.4.3 LAMEA Newborn Screening Market, by End User
1.4.4 LAMEA Newborn Screening Market, by Technology
1.4.5 LAMEA Newborn Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Newborn Screening Market
Chapter 4. LAMEA Newborn Screening Market by Product Type
4.1 LAMEA Consumables Market by Country
4.2 LAMEA Instrument Market by Country
Chapter 5. LAMEA Newborn Screening Market by Test Type
5.1 LAMEA Blood Test Market by Country
5.2 LAMEA Hearing Screening Test Market by Country
5.3 LAMEA Heart screening Market by Country
Chapter 6. LAMEA Newborn Screening Market by End User
6.1 LAMEA Hospitals Market by Country
6.2 LAMEA Clinical Laboratories Market by Country
Chapter 7. LAMEA Newborn Screening Market by Technology
7.1 LAMEA Tandem Mass Spectrometry (TMS) Market by Country
7.2 LAMEA Molecular Assays Market by Country
7.3 LAMEA Immunoassays & Enzymatic Assays Market by Country
7.4 LAMEA Hearing Screen Technology Market by Country
7.5 LAMEA Pulse Oximetry Screening Technology Market by Country
7.6 LAMEA Others Market by Country
Chapter 8. LAMEA Newborn Screening Market by Country
8.1 Brazil Newborn Screening Market
8.1.1 Brazil Newborn Screening Market by Product Type
8.1.2 Brazil Newborn Screening Market by Test Type
8.1.3 Brazil Newborn Screening Market by End User
8.1.4 Brazil Newborn Screening Market by Technology
8.2 Argentina Newborn Screening Market
8.2.1 Argentina Newborn Screening Market by Product Type
8.2.2 Argentina Newborn Screening Market by Test Type
8.2.3 Argentina Newborn Screening Market by End User
8.2.4 Argentina Newborn Screening Market by Technology
8.3 UAE Newborn Screening Market
8.3.1 UAE Newborn Screening Market by Product Type
8.3.2 UAE Newborn Screening Market by Test Type
8.3.3 UAE Newborn Screening Market by End User
8.3.4 UAE Newborn Screening Market by Technology
8.4 Saudi Arabia Newborn Screening Market
8.4.1 Saudi Arabia Newborn Screening Market by Product Type
8.4.2 Saudi Arabia Newborn Screening Market by Test Type
8.4.3 Saudi Arabia Newborn Screening Market by End User
8.4.4 Saudi Arabia Newborn Screening Market by Technology
8.5 South Africa Newborn Screening Market
8.5.1 South Africa Newborn Screening Market by Product Type
8.5.2 South Africa Newborn Screening Market by Test Type
8.5.3 South Africa Newborn Screening Market by End User
8.5.4 South Africa Newborn Screening Market by Technology
8.6 Nigeria Newborn Screening Market
8.6.1 Nigeria Newborn Screening Market by Product Type
8.6.2 Nigeria Newborn Screening Market by Test Type
8.6.3 Nigeria Newborn Screening Market by End User
8.6.4 Nigeria Newborn Screening Market by Technology
8.7 Rest of LAMEA Newborn Screening Market
8.7.1 Rest of LAMEA Newborn Screening Market by Product Type
8.7.2 Rest of LAMEA Newborn Screening Market by Test Type
8.7.3 Rest of LAMEA Newborn Screening Market by End User
8.7.4 Rest of LAMEA Newborn Screening Market by Technology
Chapter 9. Company Profiles
9.1 General Electric (GE) Co. (GE Healthcare)
9.1.1 Company Overview
9.1.1 Financial Analysis
9.1.2 Segmental and Regional Analysis
9.1.3 Research & Development Expense
9.1.4 Recent strategies and developments:
9.1.4.1 Acquisition and Mergers:
9.1.5 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Bio-Rad laboratories, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Natus Medical Incorporated
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisition and Mergers:
9.5 Masimo Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.5.2 Approvals and Trials:
9.6 Waters Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 PerkinElmer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Approvals and Trials:
9.8 AB Sciex LLC (Danaher Corporation)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Medtronic PLC (Covidien plc)
9.9.1 Company overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 SWOT Analysis
9.10. Trivitron Healthcare Pvt. Ltd.
9.10.1 Company Overview
Unique Offerings 